Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metabolic syndrome is common in African populations, needing urgent prevention and treatment.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Treatments for urinary symptoms often cause ejaculatory problems.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Platelet-rich plasma shows promise for treating erectile dysfunction, but more research is needed.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Minoxidil was first made for high blood pressure, but it was later found to help hair growth.

TCF/Lef1 is essential for skin barrier function by regulating lipid metabolism.